Daily Roundup

Resmed Reports Strong Q3 Results Driven by Healthcare Demand

Resmed Inc. delivered impressive third-quarter performance, with net revenue climbing to $1.41 billion—a 6.7% jump year-over-year. The real standout was net income, which surged 20.1% to $418.4 million, translating to diluted earnings per share of $2.92. The company's sleep and breathing health products segment led the charge with $1.26 billion in revenue, while its residential care software business contributed $155 million. With $1.01 billion in cash on hand, Resmed is well-positioned financially. Looking ahead, the company expects full-year revenue to land between $5.5 billion and $5.6 billion, with continued growth anticipated across both its core segments.

Pioneer Credit Locks In Major Bank Partnership

Pioneer Credit Limited has inked a significant three-year agreement with one of Australia's big four banks, marking another milestone in the company's expansion strategy. The company has already completed its first portfolio acquisition under the deal, snapping up approximately 17,000 customer accounts with a face value of $206 million for $14.4 million. Active servicing of these accounts kicks off in early February 2027. What's particularly noteworthy is that Pioneer is now the only purchaser with agreements in place with all four of Australia's major banks—a competitive advantage that underscores its position in the debt management space. The company remains committed to balancing returns for shareholders with appropriate outcomes for customers and its banking partners.

Orthocell Hits Sales Milestone with Remplir

Medical device company Orthocell Limited is riding momentum in the U.S. market with its nerve repair product, Remplir, posting its strongest sales month since launch. October saw the company shift 92 units for AU$279,000 in revenue—an impressive 84% jump from the average monthly sales of 50 units during the first quarter of fiscal 2027. The surge reflects growing surgeon adoption, increased repeat purchases, and a broader network of actively selling distributor representatives gaining traction across key U.S. markets. The board remains confident that this expanding market adoption can translate into sustained commercial success and significant long-term revenue potential.

Emperor Energy Locks in Drilling Rig for 2027 Operations

Emperor Energy Ltd has secured the VALARIS 107 jack-up drilling rig for its Judith-2 Appraisal Well, with the rig expected to be available in April 2027. The company has executed a full-form contract with Valaris Limited and already laid out $3.5 million upfront—comprising a $2.0 million payment upon contract execution and a $1.5 million deposit made in September. The drilling contract carries a minimum 30-day duration at an operating rate of US$165,000 per day, with additional payments scheduled for 2027 ahead of the rig's mobilization. The Judith-2 Drilling Environmental Plan has already received approval from NOPSEMA, clearing another hurdle for the project.

CAQ Holdings Maintains Stable Property Operations

CAQ Holdings Ltd reported steady performance in its property leasing business during the September quarter, with vacancy rates holding steady across its portfolio. The company signed a new warehouse lease of approximately 500 square meters during the period, adding to its revenue base. Cash reserves stood at $0.487 million at quarter's end, with no payments made to director-related parties. The company is currently in discussions to extend the terms of its debt facility, which should provide some breathing room as it navigates its funding requirements. Based on current cash levels, the company has an estimated 1.34 quarters of funding available.